A proline-rich polypeptide complex (PRP) influences inducible nitric oxide synthase in mice at the protein level

Nitric Oxide - Biology and Chemistry

Volumn 23, Issue 1, 2010, Pages 20-25

  Zabłocka, Agnieszka ^a   Ogorzałek, Antoni ^b   Macała, Józefa ^a   Janusz, Maria ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

iNOS; Liver sections; Mice; NO; Peritoneal cells; Proline rich polypeptide complex (PRP)

Indexed keywords

COLOSTRININ; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; PROLINE RICH PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; FEMALE; IMMUNOREGULATION; INFLAMMATION; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; FEMALE; HISTOCYTOCHEMISTRY; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES; PERITONEUM; PROLINE-RICH PROTEIN DOMAINS;

MUS;

EID: 77952240394     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2010.03.003     Document Type: Article

References (50)

1. Janusz M., Lisowski J., and Franek F. Isolation and characterization of proline-rich polypeptide from ovine colostrum. FEBS Lett. 49 (1974) 276-279
2. Piasecki E., Inglot A.D., Winiarska M., Krukowska K., Janusz M., and Lisowski J. Coincidence between spontaneous release of interferon and tumor necrosis factor by colostral leukocytes and the production of a colostrinine by human mammary gland after normal delivery. Arch. Immunol. Ther. Exp. 45 (1997) 109-117
3. Sokołowska A., Bednarz R., Pacewicz M., Georgiades J.A., Wilusz T., and Polanowski A. Colostrum from different mammalian species - a rich source of colostrinin. Int. Dairy J. 18 (2008) 204-209
4. M. Janusz, A. Zabłocka, Colostral proline-rich polypeptides - immunoregulatory properties and prospects of therapeutic use in Alzheimer's disease, Curr. Alzheimer Res. 26 (2009) (Epub ahead of Print).
5. Zabłocka A., Janusz M., Macała J., and Lisowski J. A proline-rich polypeptide complex and its nonapeptide fragment inhibit nitric oxide production induced in mice. Regul. Pept. 125 (2005) 35-39
6. Kubis A., Marcinkowska E., Janusz M., and Lisowski J. Studies on the mechanism of action of a proline-rich polypeptide complex (PRP). Effect on the stage of cell differentiation. Peptides 26 (2005) 2188-2192
7. Zabłocka A., Janusz M., Rybka K., Wirkus-Romanowska I., Kupryszewski G., and Lisowski J. Cytokine-inducing activity of a proline-rich polypeptide complex (PRP) from ovine colostrum and its active nonapeptide fragment analogs. Eur. Cytokine Netw. 12 (2001) 462-467
8. 2 and cytokine induction in human leukocytes. Int. Immunopharmacol. 7 (2007) 981-988
9. Basci A., Stanton G.J., Hughes T.K., Kruzel M., and Boldogh I. Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells. Cell. Mol. Neurobiol. 25 (2005) 1123-1139
10. Schuster D., Rajendran A., Hui S.W., Nicotera T., Srikrishnan T., and Kruzel M. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of β-amyloid. Neuropeptides 39 (2005) 419-426
11. Bourhim M., Kruzel M., Srikrishnan T., and Nicotera T. Linear quantitation of Aβ aggregation using Thioflavin T: reduction in fibril formation by colostrinin. J. Neurosci. Meth. 160 (2007) 264-268
12. Janusz M., Woszczyna M., Lisowski M., Kubis A., Macała J., Gotszalk T., and Lisowski J. Ovine colostrum nonapeptide affects amyloid beta aggregation. FEBS Lett. 583 (2009) 190-196
13. Popik P., Bobula B., Janusz M., Lisowski J., and Vetulani J. Colostrinin, a polypeptide isolated from early milk, facilitates learning and memory in rats. Pharmacol. Biochem. Behav. 64 (1999) 183-189
14. Steward M.G., and Banks D. Enhancement of long-term memory retention by Colostrinin in one-day-old chicks trained on a weak passive avoidance learning Paradigm. Neurobiol. Learn. Mem. 86 (2006) 66-71
15. Leszek J., Inglot A.D., Janusz M., Lisowski J., Krukowska K., and Georgiades J.A. Colostrinin®: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Arch. Immunol. Ther. Exp. 47 (1999) 377-385
16. Leszek J., Inglot A.D., Janusz M., Byczkiewicz F., Kiejna A., Georgiades J., and Lisowski J. Colostrinin®: a proline-rich polypeptide complex from ovine colostrum - a long term study of its efficacy in Alzheimer's disease. Med. Sci. Monit. 8 (2002) P193-196
17. Bilikiewicz A., and Gaus W. Colostrinin (a naturally occurring, proline-rich polypeptide mixture) in the treatment of Alzheimer's disease. J. Alzheimer's Dis. 6 (2004) 17-26
18. Heneka M.T., and O'Banion M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184 (2007) 69-91
19. Pratico D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann. N. Y. Acad. Sci. 1147 (2008) 70-78
20. Nathan C., Calingason N., Nezezon J., Ding A., Scott Lucia M., La Perle K., Fuortes M., Lin M., Ehrt S., Kwon N.S., Chen J., Vodovitz Y., Kipiani K., and Beal M.F. Protection from Alzheimer's like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J. Exp. Med. 202 (2005) 1163-1169
21. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathology and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
22. Guzik T.J., Korbut R., and Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54 (2003) 469-487
23. Bogdan C. Nitric oxide and immune response. Nat. Immunol. 2 (2001) 907-916
24. Kleinert H., Pautz A., Linker K., and Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500 (2004) 255-266
25. Zhao F., Xu H., He E.Q., Iiang Y.T., and Lin K. Inhibitory effects of sesquiterpenes from Saussurea lappa on the overproduction of nitric oxide and TNF-alpha release in LPS-activated macrophages. J. Asian Nat. Prod. Res. 10 (2008) 1045-1053
26. Zhu F., and Qian C. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1 beta and inducible nitric oxide synthase in the rat model of Alzheirmer's disease. BCM Neurosci. 7 (2006) 78-86
27. Rehni A.K., Singh T.G., Kalra R., and Singh N. Pharmacological inhibition of inducible nitric oxide synthase attenuates the development of seizures in mice. Nitric oxide 21 (2009) 120-125
28. Noman A.S., Koide N., Khuda I., Dagvadori J., Tumurkhuu G., Naiki Y., Komatsu T., Yoshida Y., and Yokochi T. Thalidomide inhibits lypopolysaccharide-induced nitric oxide production and prevents lipopolysaccharide-mediated lethality in mice. FEMS Immunol. Med. Microbiol. 56 (2009) 204-211
29. Hyun-Ye J., Youngsoo K., Sang-Yoon N., Beam J.L., Yun-bae K., Young W.Y., and Byyeongwoo A. The inhibitory effect of quercitrin galate on iNOS expression induced by lipopolysaccharide in Balb/c mice. J. Vet. Sci. 9 (2008) 267-272
30. Su-Hyun S., Hye-Young M., Ah-Reum H., Joo-Won N., Eun-Kyoung S., Seoung W.P., Sang Hyung L., and Sang Kook L. Suppresion of inducible nitric oxide synthase by (-)isoeleutherin from the bulbs of Eleutherine americana through the regulation of NF-kB activity. Int. Immunopharmacol. 9 (2009) 298-302
31. Janusz M., Starościk K., Zimecki M., Wieczorek Z., and Lisowski J. Chemical and physical characterization of a proline-rich polypeptide from sheep colostrum. Biochem J. 199 (1981) 9-15
32. Walsh K.B., Toledo A.H., Rivera-Chaver F.A., Lopez-Neblina F., and Toledo-Pereyra C.H. Inflammatory mediators of liver ischemia - reperfusion injury. Exp. Clin. Transplant. 7 (2009) 78-93
33. Zhang G.W., Fan Y.Y., Gao Y.J., and Li C. Study on nitric oxide and liver injury. Prog. Anat. Sci. 8 (2002) 75-77
34. Zhang N., Weber A., Li B., Lyons R., Contag P.R., Purchio A.F., and West D.B. An inducible nitric oxide synthase-luciferase reporter system for in vivo testing of anti-inflammatory compounds in transgenic mice. J. Immunol. 170 (2003) 6307-6319
35. Luiking Y.C., Engelen M.P., and Deutz N.E. Regulation of nitric oxide production in health disaese. Curr. Opin. Clin. Nutr. Metab. Care (2009) (Epub ahead of print)
36. Lange M., Enkhbaatar P., Nakano Y., and Traber D.L. Role of nitric oxide in shock: the large animal perspective. Front. Biosci. 14 (2009) 1979-1989
37. Kmieć Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 161 (2001) 1-151
38. Kro{combining double acute accent}ncke K.D., Fehsel K., and Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113 (1998) 147-156
39. Zhao F., Xu H., He E.Q., Jiang Y.T., and Liu K. Inhibitory effects of sesquiterpenes from Saussurea Lappa on the overproduction of nitric oxide and TNF-alpha release in LPS-activated macrophages. J. Asian Nat. Prod. Res. 10 (2008) 1045-1053
40. J.C. ter Steege, W.C. Van de Ven, P.P. Forget, W.A. Buurman, Regulation of lipopolysaccharide-induced NO synthase expression in the major organs in a mouse model. The roles of endogenous interferon-gamma, tumor necrosis factor and interleukin 10, Eur. Cytokine Netw. 11 (2000) 39-46.
41. Guler R., Olleros M.L., Vesin D., Parapanow R., Vesin C., Kantengwa S., Rubbia-Brandt L., Mensi N., Angelillo-Scherrer A., Martinez-Soria E., Tacchini-Cottier F., and Garcia I. Inhibition of inducible nitric oxide synthase protect against liver injury induced by mycobacterial infection and endotoxins. J. Hepatol. 41 (2004) 773-781
42. Kato C., Mikami M., and Saito K. Nitric oxide production and iNOS mRNA expression in mice induced by repeated stimulation with live Fusobacterium nucleatum. Microbiol. Immunol. 45 (2001) 69-78
43. Hewett J.A., and Roth R.A. Hepatic and extrahepatic pathology of bacterial lipopolysaccharides. Pharmacol. Rev. 45 (1993) 382-411
44. Osei S.Y., Ahima R.S., Fabry M.E., Nagel R.L., and Bank N. Immunochistochemical localization of hepatic oxide synthase in normal and transgenic sicle cell mice. The effect of hypoxia. Blood 9 (1996) 3583-3588
45. Musiał A., and Eissa N.T. The activity on enzyme can be controlled through the regulation of its synthesis, catalytic activity or degradation. J. Biol. Chem. 276 (2001) 24268-24273
46. Felley-Bosco E., Bender F.C., Courjault-Gautier F., Bron C., and Quest A.F. Caveolin-1 down-regulates iNOS via the proteasome pathway in human colon carcinoma cells. PNAS USA 97 (2000) 14334-14339
47. Kang J.H., Chang S.Y., Jang H.J., Kim D.B., Ryu G.R., Ko S.H., Jeong I.K., Jo Y.H., and Kim M.J. Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells. J. Endocrinol. 202 (2009) 65-75
48. Jin H.K., Ahn S.H., Yoon J.W., Pork J.W., Lee E.K., Yoo J.S., Lee J.C., Choi W.S., and Han J.W. Rapamycin down-regulates inducible nitric oxide synthase by inducing proteasomal degradation. Biol. Pharm. Bull. 32 (2009) 988-992
49. Guo H., Sun J., He H., Yu G.-C., and Du J. Antihepatotoxic effect of corn peptides against bacillus Calmette-Guerin/lipopolysaccharide-induced liver injury in mice. Food Chem. Toxicol. (2009) 10.1016/j.fct.2009.06.041
50. Salkowski C.A., Detore G., McNally R., van Rooijen N., and Vogel S.N. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo. J. Immunol. 158 (1997) 905-912